Sleep Number Announces Fourth Quarter and Full Year 2022 Results

Rhea-AI Summary

Sleep Number Corporation (Nasdaq: SNBR) reported a 1% increase in fourth quarter net sales to $498 million, while full year net sales dropped 3% to $2.11 billion. The company faced a net loss of $0.24 per diluted share for the fourth quarter, compared to a profit of $0.47 the previous year. Despite challenges such as a 13% decline in demand and rising input costs, Sleep Number generated $36 million in operating cash flow and reported an Adjusted ROIC of 17.6%. For 2023, the company forecasts diluted EPS between $1.25 and $2.00, with expectations of flat to mid-single-digit declines in net sales.

Positive

• Fourth quarter net sales increased 1% to $498 million.
• Generated $36 million in operating cash flows for the year.
• Adjusted ROIC was 17.6% for the trailing twelve-month period.

Negative

• Full year net sales decreased 3% to $2.11 billion.
• Net loss per diluted share of $0.24 compared to net income of $0.47 last year.
• Gross profit decreased 9% to $1.2 billion, impacted by input cost increases.

• Fourth quarter net sales increased 1% versus the prior year
• Full year net sales decreased 3% to $2.11 billion, with full year diluted earnings per share (EPS) of $1.60
• Generated $36 million of operating cash flows for the year and an Adjusted ROIC of 17.6%
• Provides 2023 earnings outlook of $1.25 to $2.00 per diluted share

MINNEAPOLIS--(BUSINESS WIRE)-- Sleep Number Corporation (Nasdaq: SNBR) today reported results for the year ended December 31, 2022.

“As we navigated a series of significant macro challenges in 2022, we achieved important strategic advancements that strengthen our sleep technology leadership. These advancements will position Sleep Number to capitalize on profitable growth opportunities when the consumer environment improves,” said Shelly Ibach, Chair, President and CEO. “Consumer response to our best innovation to date – the new Climate360 smart bed – has been strong, and we are excited to introduce our next-generation smart beds beginning in the second quarter. We are seeing improved demand trends early in the year, with the consistent flow of microchips supporting normalized delivery times for our smart beds and adjustable bases. I am grateful to our Sleep Number team for their resilience and commitment to our purpose of improving the health and wellbeing of society through higher quality sleep.”

Fourth Quarter Overview

• Net sales were $498 million, up 1% compared with $492 million last year
• Gross profit decreased 3% to $272 million, or 54.7% of net sales, compared with $280 million or 56.9% of net sales for the prior year
• Net loss per diluted share of $0.24, compared to net income per diluted share of $0.47 last year

Full Year Overview

• Net sales decreased 3% to $2.11 billion in 2022; full year demand declined 13% versus the prior year, partially offset by the delivery of excess backlog
• Gross profit decreased 9% to $1.2 billion, or 56.9% of net sales, including the impact of year-over-year input cost increases and inefficiencies from semiconductor chip constraints, partially offset by pricing actions
• Diluted EPS of $1.60, compared to $6.16 last year

Cash Flows and Liquidity Review

• Generated $36 million in net cash from operating activities
• Invested $69 million in capital expenditures; suspended share repurchases in the second quarter of 2022
• Leverage ratio of 4.4x EBITDAR at the end of the fourth quarter versus covenant maximum of 5.0x; $359 million of liquidity remains against current credit facility
• Adjusted return on invested capital (Adjusted ROIC) was 17.6% for the trailing twelve-month period

Financial Outlook

The company expects 2023 diluted EPS of $1.25 to $2.00. The 2023 outlook assumes net sales are flat to down mid-single digits versus the prior year. The outlook assumes gross margin rate improves by more than 150 basis points versus 2022. The company expects to generate over $100 million of operating cash flow for the year and positive free cash flows. The company anticipates 2023 capital expenditures of $50 million to $60 million and is planning no share repurchases during the year.

Conference Call Information

Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EST (4 p.m. CST; 2 p.m. PST) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days.

About Sleep Number Corporation

Sleep Number is a wellness technology company. Over 14 million people have had their lives improved by our award-winning sleep innovations and are experiencing the physical, mental and emotional benefits of life-changing sleep performance. Our proprietary smart beds combine the physical and digital worlds, integrating exceptional sleep with a highly advanced digital technology platform. This means only Sleep Number can provide a dynamic, adjustable and adaptive sleep experience that effortlessly responds to the needs of each sleeper. Our millions of Smart Sleepers benefit from their smart bed changing with them, over time; it is unique, like they are.

Our differentiated business model is guided by our purpose to improve the health and wellbeing of society through higher quality sleep. We partner with world-leading sleep and health institutions to bring the power of 18 billion hours of longitudinal sleep data to sleep science and research. Our retail experience meets our consumers whenever and wherever they choose – through online and in-store touchpoints. And our 5,000 mission-driven team members passionately deliver individualized sleep experiences for everyone.

For life-changing sleep, visit one of our 670 stores, our newsroom and investor relations sites, or SleepNumber.com

Forward-looking Statements

Statements used in this news release relating to future plans, events, financial results or performance, such as the company’s outlook for full-year 2023 diluted EPS, are forward-looking statements subject to certain risks and uncertainties including, among others, such factors as current and future economic conditions and consumer sentiment; increases in interest rates, which have increased the cost of servicing the company’s indebtedness; availability of attractive and cost-effective consumer credit options; operating with minimal levels of inventory, which may leave the company vulnerable to supply shortages; Sleep Number’s dependence on, and ability to maintain strong working relationships with key suppliers and third parties; rising commodity costs or third-party logistics costs and other inflationary pressures; risks inherent in global-sourcing activities, including tariffs, geo-political turmoil, war, strikes, labor challenges, government-mandated work closures, outbreaks of pandemics or contagious diseases, and resulting supply shortages and production and delivery delays and disruptions; risks of disruption due to health epidemics or pandemics, such as the COVID-19 pandemic; regional risks related to having global operations and suppliers, including climate and other disasters; the effectiveness of the company’s marketing strategy and promotional efforts; the execution of Sleep Number’s Total Retail distribution strategy; ability to achieve and maintain high levels of product quality; ability to improve and expand Sleep Number’s product line and execute successful new product introductions; ability to prevent third parties from using the company’s technology or trademarks, and the adequacy of its intellectual property rights to protect its products and brand; ability to compete; risks of disruption in the operation of any of the company’s main manufacturing, distribution, logistics, home delivery, product development or customer service operations; the company’s ability to comply with existing and changing government regulation; pending or unforeseen litigation and the potential for associated adverse publicity; the adequacy of the company’s and third-party information systems and costs and disruptions related to upgrading or maintaining these systems; the company’s ability to withstand cyber threats that could compromise the security of its systems, result in a data breach or business disruption; Sleep Number’s ability, and the ability of its suppliers and vendors, to attract, retain and motivate qualified personnel; the volatility of Sleep Number stock; environmental, social and governance (ESG) risks, including increasing regulation and stakeholder expectations; and the company’s ability to adapt to climate change and readiness for legal or regulatory responses thereto.​ Additional information concerning these and other risks and uncertainties is contained in the company’s filings with the Securities and Exchange Commission (SEC), including the Annual Report on Form 10-K, and other periodic reports filed with the SEC. The company has no obligation to publicly update or revise any of the forward-looking statements in this news release.

SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Operations
(unaudited – in thousands, except per share amounts)
	Three Months Ended
	December 31,				% of			January 1,			% of
	2022				Net Sales			2022			Net Sales
Net sales	$	497,528			100.0	%		$	491,984		100.0	%
Cost of sales		225,562			45.3	%			212,260		43.1	%
Gross profit		271,966			54.7	%			279,724		56.9	%
Operating expenses:
Sales and marketing		219,224			44.1	%			220,236		44.8	%
General and administrative		37,217			7.5	%			29,924		6.1	%
Research and development		14,613			2.9	%			14,907		3.0	%
Total operating expenses		271,054			54.5	%			265,067		53.9	%
Operating income		912			0.2	%			14,657		3.0	%
Interest expense, net		7,633			1.5	%			1,845		0.4	%
(Loss) income before income taxes		(6,721	)		(1.4	%)			12,812		2.6	%
Income tax (benefit) expense		(1,291	)		(0.3	%)			1,671		0.3	%
Net (loss) income	$	(5,430	)		(1.1	%)		$	11,141		2.3	%
Net (loss) income per share – basic	$	(0.24	)					$	0.49
Net (loss) income per share – diluted	$	(0.24	)					$	0.47
Reconciliation of weighted-average
shares outstanding:
Basic weighted-average shares outstanding		22,249							22,939
Dilutive effect of stock-based awards 1		-							877
Diluted weighted-average shares outstanding 1		22,249							23,816

1 For the three months ended December 31, 2022, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.

SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Operations
(unaudited – in thousands, except per share amounts)
	Twelve Months Ended
	December 31,			% of			January 1,			% of
	2022			Net Sales			2022			Net Sales
Net sales	$	2,114,297		100.0	%		$	2,184,949		100.0	%
Cost of sales		912,001		43.1	%			866,102		39.6	%
Gross profit		1,202,296		56.9	%			1,318,847		60.4	%
Operating expenses:
Sales and marketing		919,629		43.5	%			905,359		41.4	%
General and administrative		153,266		7.2	%			161,412		7.4	%
Research and development		61,521		2.9	%			58,540		2.7	%
Total operating expenses		1,134,416		53.7	%			1,125,311		51.5	%
Operating income		67,880		3.2	%			193,536		8.9	%
Interest expense, net		18,985		0.9	%			6,245		0.3	%
Income before income taxes		48,895		2.3	%			187,291		8.6	%
Income tax expense		12,285		0.6	%			33,545		1.5	%
Net income	$	36,610		1.7	%		$	153,746		7.0	%
Net income per share – basic	$	1.63					$	6.40
Net income per share – diluted	$	1.60					$	6.16
Reconciliation of weighted-average
shares outstanding:
Basic weighted-average shares outstanding		22,396						24,038
Dilutive effect of stock-based awards		456						909
Diluted weighted-average shares outstanding		22,852						24,947

SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Balance Sheets
(unaudited – in thousands, except per share amounts)
subject to reclassification
	December 31,				January 1,
	2022				2022
Assets
Current assets:
Cash and cash equivalents	$	1,792			$	2,389
Accounts receivable, net of allowances
of $1,267 and $924, respectively		26,005				25,718
Inventories		114,034				105,644
Prepaid expenses		16,006				18,953
Other current assets		39,921				54,917
Total current assets		197,758				207,621
Non-current assets:
Property and equipment, net		200,605				195,128
Operating lease right-of-use assets		397,755				371,133
Goodwill and intangible assets, net		68,065				70,468
Deferred income taxes		7,958				-
Other non-current assets		81,795				75,190
Total assets	$	953,936			$	919,540
Liabilities and Shareholders’ Deficit
Current liabilities:
Borrowings under revolving credit facility	$	459,600			$	382,500
Accounts payable		176,207				162,547
Customer prepayments		73,181				129,499
Accrued sales returns		25,594				22,368
Compensation and benefits		31,291				51,240
Taxes and withholding		23,622				22,087
Operating lease liabilities		79,533				72,360
Other current liabilities		60,785				64,177
Total current liabilities		929,813				906,778
Non-current liabilities:
Deferred income taxes		-				688
Operating lease liabilities		356,879				336,192
Other non-current liabilities		105,421				100,835
Total non-current liabilities		462,300				437,715
Total liabilities		1,392,113				1,344,493
Shareholders’ deficit:
Undesignated preferred stock; 5,000 shares authorized,
no shares issued and outstanding		-				-
Common stock, $0.01 par value; 142,500 shares authorized,
22,014 and 22,683 shares issued and outstanding, respectively		220				227
Additional paid-in capital		5,182				3,971
Accumulated deficit		(443,579	)			(429,151	)
Total shareholders’ deficit		(438,177	)			(424,953	)
Total liabilities and shareholders’ deficit	$	953,936			$	919,540

SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(unaudited - in thousands)
subject to reclassification
		Twelve Months Ended
		December 31,				January 1,
		2022				2022
Cash flows from operating activities:
Net income		$	36,610			$	153,746
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization			67,401				60,394
Stock-based compensation			13,223				23,214
Net loss on disposals and impairments of assets			291				37
Deferred income taxes			(8,646	)			446
Changes in operating assets and liabilities:
Accounts receivable			(287	)			6,153
Inventories			(11,560	)			(24,282	)
Income taxes			1,356				(3,066	)
Prepaid expenses and other assets			19,379				(13,836	)
Accounts payable			(4,743	)			54,405
Customer prepayments			(56,318	)			57,482
Accrued compensation and benefits			(19,821	)			(24,790	)
Other taxes and withholding			179				1,814
Other accruals and liabilities			(926	)			8,293
Net cash provided by operating activities			36,138				300,010
Cash flows from investing activities:
Purchases of property and equipment			(69,454	)			(66,900	)
Proceeds from sales of property and equipment			49				257
Investment in non-marketable equity securities			(1,202	)			-
Net cash used in investing activities			(70,607	)			(66,643	)
Cash flows from financing activities:
Net increase in short-term borrowings			97,647				145,473
Repurchases of common stock			(64,188	)			(382,376	)
Proceeds from issuance of common stock			1,131				4,441
Debt issuance costs			(718	)			(2,759	)
Net cash provided by (used in) financing activities			33,872				(235,221	)
Net decrease in cash and cash equivalents			(597	)			(1,854	)
Cash and cash equivalents, at beginning of period			2,389				4,243
Cash and cash equivalents, at end of period		$	1,792			$	2,389

SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Supplemental Financial Information
(unaudited)
	Three Months Ended								Twelve Months Ended
	December 31,				January 1,				December 31,				January 1,
	2022				2022				2022				2022
Percent of sales:
Retail stores		84.8	%			85.8	%			86.3	%			87.1	%
Online, phone, chat and other		15.2	%			14.2	%			13.7	%			12.9	%
Total Company		100.0	%			100.0	%			100.0	%			100.0	%
Sales change rates:
Retail comparable-store sales		(3	%)			(11	%)			(8	%)			19	%
Online, phone and chat		10	%			(11	%)			4	%			4	%
Total Retail comparable sales change		(1	%)			(11	%)			(6	%)			17	%
Net opened/closed stores and other		2	%			(2	%)			3	%			1	%
Total Company		1	%			(13	%)			(3	%)			18	%
Stores open:
Beginning of period		662				632				648				602
Opened		14				22				49				77
Closed		(6	)			(6	)			(27	)			(31	)
End of period		670				648				670				648
Other metrics:
Average sales per store ($ in 000's) 1	$	3,281			$	3,600
Average sales per square foot 1	$	1,081			$	1,212
Stores > $2 million net sales 2		76	%			84	%
Stores > $3 million net sales 2		36	%			48	%
Average revenue per smart bed unit 3	$	5,361			$	5,309			$	5,403			$	5,102

1 Trailing twelve months Total Retail comparable sales per store open at least one year.

2 Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).

3 Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)

(in thousands)

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:

		Three Months Ended									Trailing Twelve Months Ended
		December 31,				January 1,					December 31,				January 1,
		2022				2022					2022				2022
Net (loss) income		$	(5,430	)		$	11,141				$	36,610			$	153,746
Income tax (benefit) expense			(1,291	)			1,671					12,285				33,545
Interest expense			7,633				1,844					18,985				6,245
Depreciation and amortization			17,843				15,434					66,626				59,779
Stock-based compensation			4,638				3,512					13,223				23,214
Asset impairments			17				60					295				172
Adjusted EBITDA		$	23,410			$	33,662				$	148,024			$	276,701
Free Cash Flow
(in thousands)
		Three Months Ended									Trailing Twelve Months Ended
		December 31,				January 1,					December 31,				January 1,
		2022				2022					2022				2022
Net cash (used in) provided by operating activities		$	(43,984	)		$	7,326				$	36,138			$	300,010
Subtract: Purchases of property and equipment			16,646				17,530					69,454				66,900
Free cash flow		$	(60,630	)		$	(10,204	)			$	(33,316	)		$	233,110
Calculation of Net Leverage Ratio under Revolving Credit Facility
(in thousands)
											Trailing Twelve Months Ended
											December 31,				January 1,
											2022				2022
Borrowings under revolving credit facility											$	459,600			$	382,500
Outstanding letters of credit												5,947				3,997
Finance lease obligations												420				537
Consolidated funded indebtedness											$	465,967			$	387,034
Capitalized operating lease obligations1												663,939				610,072
Total debt including capitalized operating lease obligations (a)											$	1,129,906			$	997,106
Adjusted EBITDA (see above)											$	148,024			$	276,701
Consolidated rent expense												110,657				101,679
Consolidated EBITDAR (b)											$	258,681			$	378,380
Net Leverage Ratio under revolving credit facility (a divided by b)											4.4 to 1.0				2.6 to 1.0

1 A multiple of six times annual rent expense is used as an estimate for capitalizing our operating lease obligations in accordance with our credit facility.

Note - Our Adjusted EBITDA and EBITDAR calculations, Free Cash Flow data and Calculation of Net Leverage Ratio under Revolving Credit Facility are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Calculation of Return on Invested Capital (Adjusted ROIC)

(in thousands)

Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

				Trailing Twelve Months Ended
				December 31, 2022				January 1, 2022
Adjusted net operating profit after taxes (Adjusted NOPAT)
Operating income				$	67,880			$	193,536
Add: Operating lease interest 1					25,912				24,763
Less: Income taxes 2					(23,542	)			(52,807	)
Adjusted NOPAT				$	70,250			$	165,492
Average adjusted invested capital
Total deficit				$	(438,177	)		$	(424,953	)
Add: Long-term debt 3					460,020				383,037
Add: Operating lease obligations 4					436,412				408,552
Total adjusted invested capital at end of period				$	458,255			$	366,636
Average adjusted invested capital 5				$	400,038			$	350,597
Adjusted ROIC 6					17.6	%			47.2	%

1 Represents the interest expense component of lease expense included in our financial statements under ASC 842.

2 Reflects annual effective income tax rates, before discrete adjustments, of 25.1% and 24.2% for December 31, 2022 and January 1, 2022, respectively.

3 Long-term debt includes existing finance lease liabilities.

4 Reflects operating lease liabilities included in our financial statements under ASC 842.

5 Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances.

6 Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.

Note - Our Adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. We updated our Adjusted ROIC calculation for the reporting period ended December 31, 2022, to reflect adjustments consistent with ASC 842, Leases. The prior period has been updated to reflect this calculation."

GAAP - generally accepted accounting principles in the U.S.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005059/en/

Investor Contact: Dave Schwantes; (763) 551-7498; investorrelations@sleepnumber.com

Media Contact: Julie Elepano; (414) 732-9840; julie.elepano@sleepnumber.com

Source: Sleep Number Corporation

FAQ

What were Sleep Number's fourth quarter net sales for 2022?

Sleep Number's fourth quarter net sales increased by 1% to $498 million.

What is Sleep Number's earnings outlook for 2023?

Sleep Number expects diluted EPS for 2023 to be between $1.25 and $2.00.

How did Sleep Number perform financially in 2022?

In 2022, Sleep Number had full year net sales of $2.11 billion, down 3% from the previous year, and a net loss of $0.24 per diluted share in Q4.

What is the Adjusted ROIC for Sleep Number?

Sleep Number's Adjusted ROIC was 17.6% for the trailing twelve-month period.

What factors affected Sleep Number's 2022 performance?

Sleep Number faced challenges with a 13% decline in demand and rising input costs due to semiconductor constraints.